Citation: L. Sinha et al., IDIOPATHIC BILE-ACID MALABSORPTION - QUALITATIVE AND QUANTITATIVE CLINICAL-FEATURES AND RESPONSE TO CHOLESTYRAMINE, Alimentary pharmacology & therapeutics, 12(9), 1998, pp. 839-844
Citation: Pr. Talbot et al., A CLINICAL ROLE FOR TC-99M-HMPAO SPECT IN THE INVESTIGATION OF DEMENTIA, Journal of Neurology, Neurosurgery and Psychiatry, 64(3), 1998, pp. 306-313
Authors:
VARMA AR
TALBOT PR
SNOWDEN JS
LLOYD JJ
TESTA HJ
NEARY D
Citation: Ar. Varma et al., A TC-99M-HMPAO SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY STUDY OF LEWY-BODY-DISEASE, Journal of neurology, 244(6), 1997, pp. 349-359
Citation: Pr. Talbot et al., THE CONTRIBUTION OF SINGLE-PHOTON EMISSION TOMOGRAPHY TO THE CLINICAL-DIFFERENTIATION OF DEGENERATIVE CORTICAL BRAIN DISORDERS, Journal of neurology, 242(9), 1995, pp. 579-586
Citation: Jm. James et Hj. Testa, THE USE OF TC-99(M)-TECHNEGAS IN THE INVESTIGATION OF PATIENTS WITH PULMONARY THROMBOEMBOLISM, Nuclear medicine communications, 16(10), 1995, pp. 802-810
Citation: Pr. Talbot et al., INTERRELATION BETWEEN CLASSIC MOTOR-NEURON DISEASE AND FRONTOTEMPORALDEMENTIA - NEUROPSYCHOLOGICAL AND SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY STUDY, Journal of Neurology, Neurosurgery and Psychiatry, 58(5), 1995, pp. 541-547
Citation: Bd. Edwards et al., INTERRELATIONSHIP BETWEEN SERUM CONCENTRATIONS OF 1,25-DIHYDROXYVITAMIN-D, PARATHYROID-HORMONE AND RENAL HEMODYNAMICS AFTER LOW-DOSE CYCLOSPORINE, Mineral and electrolyte metabolism, 20(5), 1994, pp. 250-254
Citation: Pr. Talbot et al., CHOICE OF REFERENCE REGION IN THE QUANTIFICATION OF SINGLE-PHOTON EMISSION TOMOGRAPHY IN PRIMARY DEGENERATIVE DEMENTIA, European journal of nuclear medicine, 21(6), 1994, pp. 503-508
Citation: Jj. Lloyd et al., THE INFLUENCE OF INHALATION TECHNIQUE ON TECHNEGAS PARTICLE DEPOSITION AND IMAGE APPEARANCE IN NORMAL VOLUNTEERS, European journal of nuclear medicine, 21(5), 1994, pp. 394-398
Citation: Bd. Edwards et al., ANGIOTENSIN-II AS A RISK FACTOR FOR CYCLOSPORINE NEPHROTOXICITY IN PATIENTS WITH PSORIASIS, Clinical nephrology, 41(6), 1994, pp. 350-356
Citation: Bd. Edwards et al., ALTERED CLEARANCE OF N-1 METHYLNICOTINAMIDE ASSOCIATED WITH THE USE OF LOW-DOSES OF CYCLOSPORINE, American journal of kidney diseases, 23(1), 1994, pp. 23-30
Authors:
GRAY RJM
HORNER K
TESTA HJ
LLOYD JJ
SLOAN P
Citation: Rjm. Gray et al., CONDYLAR HYPERPLASIA - CORRELATION OF HISTOLOGICAL AND SCINTIGRAPHIC FEATURES, Dento-maxillo-facial radiology, 23(2), 1994, pp. 103-107
Authors:
BROWN JH
VITES NP
TESTA HJ
PRESCOTT MC
HUNT LP
GOKAL R
MALLICK NP
Citation: Jh. Brown et al., VALUE OF THALLIUM MYOCARDIAL IMAGING IN THE PREDICTION OF FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WITH END-STAGE RENAL-FAILURE, Nephrology, dialysis, transplantation, 8(5), 1993, pp. 433-437
Citation: Bd. Edwards et al., MODULATION OF ABNORMALITIES IN RENAL HEMODYNAMICS AND VASOACTIVE MEDIATORS BY NIFEDIPINE IN PATIENTS WITH PSORIASIS ON LOW-DOSE CYCLOSPORINE, Nephrology, dialysis, transplantation, 8(10), 1993, pp. 1071-1078